Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Tuberc Lung Dis. 1998 May;2(5):360-4.

Two-year follow-up of directly-observed intermittent regimens for smear-positive pulmonary tuberculosis in China.

Author information

1
The Anti-Tuberculosis Institute of Hebei Province, People's Republic of China.

Abstract

SETTING:

The tuberculosis component of the Infectious and Endemic Disease Control Project in the People's Republic of China is the largest single tuberculosis control project in the world using directly-observed therapy and standardized intermittent regimens.

OBJECTIVE:

To determine the two-year relapse and mortality rates following completion of treatment.

DESIGN:

A prospective cohort study of 649 cases cured in this project. The 306 new and 343 retreatment cases were treated under field conditions with 2H3R3Z3S3/4H3R3 and 2H3R3Z3E3S3/6H3R3E3, respectively. Following treatment completion, two sputum samples were collected every six months for two years and examined for acid-fast bacilli. Causes of death were identified.

RESULTS:

The two-year relapse rates for new and retreatment cases were 3.3% and 5.6%, respectively. Retreatment cases with delayed sputum conversion had a greater risk for subsequent relapse. The two-year mortality rate for new and retreatment cases was 3.3% and 8.5%, respectively. The higher mortality rate in retreatment cases was not attributable to relapse of disease, but rather to non-infectious sequelae of tuberculosis.

CONCLUSION:

The use of directly-observed intermittent regimens is effective in permanently removing infectious tuberculosis cases from the community.

PMID:
9613630
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Ingenta plc
    Loading ...
    Support Center